Michael Haglund Presented with Alumni Humanitarian Award
When Duke neurosurgeon Michael Haglund, MD, PhD, took his first humanitariam trip to Uganda 12 years ago, he says he "saw the need, and it was beyond great."
Scott E. Page to Present Allan H. Friedman Lecture Aug. 29
Scott E. Page, PhD, director of the Center for the Study of Complex Systems at the University of Michigan, will present the Allan H. Friedman Lecture on August 29, 2018.
The Optimist: Getting to Know Henry Friedman
Henry S. Friedman, MD, is the James B. Powell Jr. Professor of Neuro-Oncology, and a well-known face of the Preston Robert Tisch Brain Tumor Center at Duke.
Duke Study: Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%
Results are being presented today at the International Conference on Brain Tumor Research and Therapy in Norway and published in The New England Journal of Medicine.
Four Things to Know About Adult Scoliosis
Shaffrey Named Spine Chief
Thelma's Story: Breaking New Ground
Was it Alzheimer’s disease? Vertigo? Thelma Cooper didn’t know what was causing her blackouts, memory lapses, and debilitating nausea, and the lack of answers drove her into a depression.
Treatment Advances Give Hope to People with Brain Metastases
Lisa VanTress didn’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016.
Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.